Filing Details

Accession Number:
0000899243-20-008551
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-16 21:50:40
Reporting Period:
2020-03-12
Accepted Time:
2020-03-16 21:50:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689575 Katherine Stueland C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 91,733 $0.00 224,786 No 4 A Direct
Common Stock Disposition 2020-03-13 935 $11.58 223,851 No 4 S Direct
Common Stock Disposition 2020-03-13 65 $12.60 223,786 No 4 S Direct
Common Stock Disposition 2020-03-16 10,684 $11.79 213,102 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares issued upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the remaining award vesting on each of March 12, 2021 and March 12, 2022, subject to continued service with the Issuer through the applicable vesting dates.
  2. These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019.
  3. Represents weighted average sale price. Actual sale prices ranged from $11.20 to $12.00.
  4. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  5. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
  6. Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
  7. Includes an aggregate of 172,173 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.